title: [Treatment of cervical and vulvar condylomata by co2 laser also with a immunostimulant].
abstract: Condylomata are of viral origin and are found in increasing frequency. The CO2 laser has contributed significantly to the treatment of this condition with a failure rate approximating 35 p. cent of cases. Two groups of patients with cervical or vulvovaginal condylomata were treated by CO2 laser or by CO2 laser and Isoprinosine. After the initial treatment, there were 31,6 p. cent failures in the group treated only by CO2 laser in patients with cervical condylomata, and 66,3 p. cent failures in those with vulvovaginal condylomata. Following 3 laser treatments, there was a 5,3 p. cent failure rate with the cervical condylomata, and 33,3 p. cent with the vulvovaginal condylomata. In the group treated by CO2 laser and Isoprinosine, there were 6,9 p. cent failures in patients with cervical condylomata and 5,7 p. cent failures in those with vulvovaginal condylomata following the initial treatment. After 3 treatments there were no failures. The combined use of CO2 laser and Isoprinosine reduces significantly the number of recurring condyloma acuminata, and appears to us to be an effective form of treatment.
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D003218:Condylomata Acuminata / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D006801:Humans; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000627:therapeutic use*; D053685:Laser Therapy
chemical_list: D000276:Adjuvants, Immunologic; D007288:Inosine; D007542:Inosine Pranobex
vernacular_title: Traitement des condylomes cervicaux et vulvaires par laser CO2 associé à un immunostimulant.